Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
J Clin Oncol. 2024 Mar 27:JCO2301500. doi: 10.1200/JCO.23.01500. Online ahead of print.
J Clin Oncol. 2024.
PMID: 38537155
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study.
Hurvitz SA, Bardia A, Quiroga V, Park YH, Blancas I, Alonso-Romero JL, Vasiliev A, Adamchuk H, Salgado M, Yardley DA, Berzoy O, Zamora-Auñón P, Chan D, Spera G, Xue C, Ferreira E, Badovinac Crnjevic T, Pérez-Moreno PD, López-Valverde V, Steinseifer J, Fernando TM, Moore HM, Fasching PA; coopERA Breast Cancer study group.
Hurvitz SA, et al. Among authors: perez moreno pd.
Lancet Oncol. 2023 Sep;24(9):1029-1041. doi: 10.1016/S1470-2045(23)00268-1.
Lancet Oncol. 2023.
PMID: 37657462
Free article.
Clinical Trial.
Item in Clipboard
Latest generation estrogen receptor degraders for the treatment of hormone receptor-positive breast cancer.
Chen YC, Yu J, Metcalfe C, De Bruyn T, Gelzleichter T, Malhi V, Perez-Moreno PD, Wang X.
Chen YC, et al. Among authors: perez moreno pd.
Expert Opin Investig Drugs. 2022 Jun;31(6):515-529. doi: 10.1080/13543784.2021.1983542. Epub 2021 Oct 25.
Expert Opin Investig Drugs. 2022.
PMID: 34694932
Review.
Item in Clipboard
Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer.
Ardizzoni A, Azevedo S, Rubio-Viqueira B, Rodríguez-Abreu D, Alatorre-Alexander J, Smit HJM, Yu J, Syrigos K, Trunzer K, Patel H, Tolson J, Cardona A, Perez-Moreno PD, Newsom-Davis T.
Ardizzoni A, et al. Among authors: perez moreno pd.
J Immunother Cancer. 2021 Mar;9(3):e001865. doi: 10.1136/jitc-2020-001865.
J Immunother Cancer. 2021.
PMID: 33737339
Free PMC article.
Clinical Trial.
Item in Clipboard
A randomized, double-blind, phase III study comparing two doses of erlotinib for second-line treatment of current smokers with advanced non-small-cell lung cancer (CurrentS).
Smit EF, Wu YL, Gervais R, Zhou C, Felip E, Feng J, Guclu SZ, Hoiczyk M, Dorokhova E, Freudensprung U, Grange S, Perez-Moreno PD, Mitchell L, Reck M.
Smit EF, et al. Among authors: perez moreno pd.
Lung Cancer. 2016 Sep;99:94-101. doi: 10.1016/j.lungcan.2016.06.019. Epub 2016 Jun 27.
Lung Cancer. 2016.
PMID: 27565921
Clinical Trial.
Item in Clipboard
Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis.
Bottaro FJ, Elizondo MC, Doti C, Bruetman JE, Perez Moreno PD, Bullorsky EO, Ceresetto JM.
Bottaro FJ, et al. Among authors: perez moreno pd.
Thromb Haemost. 2008 Jun;99(6):1104-11. doi: 10.1160/TH07-12-0759.
Thromb Haemost. 2008.
PMID: 18521515
Item in Clipboard
Cite
Cite